Prevalence of hepatitis C virus genotypes in risk groups in the Republic of Macedonia: A 5 years survey

Journal of Medical Virology

Volumn 85, Issue 12, 2013, Pages 2072-2078

  Kiprijanovska, Sanja ^a   Davalieva, Katarina ^a   Noveski, Predrag ^a   Sukarova Stefanovska, Emilija ^a   Plaseska Karanfilska, Dijana ^a  

^a MACEDONIAN ACADEMY OF SCIENCES AND ARTS   (Macedonia)

Author keywords

Genotypes; Hemodialysis; Hepatitis C virus; Intravenous drug users; Prevalence; R Macedonia

Indexed keywords

OLIGONUCLEOTIDE;

AGE; ARTICLE; BODY PIERCING; COHORT ANALYSIS; DENTAL PROCEDURE; DISEASE ASSOCIATION; FEMALE; GENDER; GENOTYPE; HEALTH SURVEY; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ABUSE; MACEDONIA (REPUBLIC); MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEEDLE; RECIPIENT; RETROSPECTIVE STUDY; RISK FACTOR; TATTOOING; VIRUS TRANSMISSION;

HEPATITIS C VIRUS;

GENOTYPES; HEMODIALYSIS; HEPATITIS C VIRUS; INTRAVENOUS DRUG USERS; PREVALENCE; R MACEDONIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INFANT; INFANT, NEWBORN; MACEDONIA (REPUBLIC); MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 84884988920     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23706     Document Type: Article

References (47)

1. Abacioglu YH, Davidson F, Tuncer S, Yap PL, Ustacelebi S, Yulug N, Simmonds P. 1995. The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat 2:297-301.
2. Ahmetagic S, Salkic N, Cickusic E, Zerem E, Mott-Divkovic S, Tihic N, Smriko-Nuhanovic A. 2009. Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in northeastern Bosnia and Herzegovina. Bosn J Basic Med Sci 9:278-282.
3. Balogun MA, Laurichesse H, Ramsay ME, Sellwood J, Westmoreland D, Paver WK, Pugh SF, Zuckerman M, Pillay D, Wreghitt T. 2003. Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: A pilot for a sentinel laboratory-based surveillance. Commun Dis Public Health 6:34-39.
4. Caramelo C, Navas S, Alberola ML, Bermejillo T, Reyero A, Carreno V. 1994. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 66:470-473.
5. Cenci M, Massi M, Alderisio M, De Soccio G, Recchia O. 2007. Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy: An update and report of a new method of HCV genotyping. Anticancer Res 27:1219-1222.
6. Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM. 1997. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 78:1341-1347.
7. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455.
8. Ciccozzi M, Zehender G, Cento V, Lo Presti A, Teoharov P, Pavlov I, Bogdanova V, Perno CF, Ciotti M. 2011. Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users. J Med Virol 83:1565-1570.
9. De Carvalho A, Martinho A, Leitao J, Cipriano MA, Coimbra H, Porto A. 2000. HCV genotypes. Liver histopathology and immunologic profile in four groups of patients. Acta Med Port 13:67-75.
10. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, Simmonds P. 1994. Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease. Hepatology 19:13-18.
11. Echevarria JM, Leon P, Pozo F, Avellon A. 2006. Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996-2004). Enferm Infecc Microbiol Clin 24:20-25.
12. Efremov DG, Dimovski AJ, Efremov GD. 1991. Detection of beta-thalassemia mutations by ASO hybridization of PCR amplified DNA with digoxigenin ddUTP labeled oligonucleotides. Hemoglobin 15:525-533.
13. Esteban JI, Sauleda S, Quer J. 2008. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 48:148-162.
14. Fabrizi F, Messa P, Martin P. 2008. Transmission of hepatitis C virus infection in hemodialysis: Current concepts. Int J Artif Organs 31:1004-1016.
15. Freeman AJ, Zekry A, Whybin LR, Harvey CE, van Beek IA, de Kantzow SL, Rawlinson WD, Boughton CR, Robertson PW, Marinos G, Lloyd AR. 2000. Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s. Med J Aust 172:588-591.
16. Ghany MG, Strader DB, Thomas DL, Seeff LB, American Association for the Study of Liver D. 2009. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 49:1335-1374.
17. Han JH, Shyamala V, Richman KH, Brauer MJ, Irvine B, Urdea MS, Tekamp-Olson P, Kuo G, Choo QL, Houghton M. 1991. Characterization of the terminal regions of hepatitis C viral RNA: Identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Proc Natl Acad Sci USA 88:1711-1715.
18. Hnatyszyn HJ. 2005. Chronic hepatitis C and genotyping: The clinical significance of determining HCV genotypes. Antivir Ther 10:1-11.
19. Hubmann R, Zazgornik J, Gabriel C, Garbeis B, Blauhut B. 1995. Hepatitis C virus-Does it penetrate the haemodialysis membrane? PCR analysis of haemodialysis ultrafiltrate and whole blood. Nephrol Dial Transplant 10:541-542.
20. Kalinina O, Norder H, Vetrov T, Zhdanov K, Barzunova M, Plotnikova V, Mukomolov S, Magnius LO. 2001. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol 65:517-524.
21. Katsoulidou A, Sypsa V, Tassopoulos NC, Boletis J, Karafoulidou A, Ketikoglou I, Tsantoulas D, Vafiadi I, Hatzis G, Skoutelis A, Akriviadis E, Vasiliadis T, Kitis G, Magiorkinis G, Hatzakis A. 2006. Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 13:19-27.
22. KDIGO. 2008. Guideline 3: Preventing HCV transmission in hemodialysis units. Kidney Int 73:S46-S52.
23. Kiprijanovska S, Sukarova-Stefanovska E, Novevski P, Chalovska V, Polenakovic M, Plaseska-Karanfilska D. 2012. Study of the hepatitis C virus in the Republic of Macedonia. Balkan J Med Genet 15:67-69.
24. Krekulova L, Rehak V, Madrigal N, Johnson M, Killoran P, Riley LW. 2001. Genotypic and epidemiologic characteristics of hepatitis C virus infections among recent injection drug user and nonuser populations. Clin Infect Dis 33:1435-1438.
25. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, Lin C, Lai C, Leong S, Medgyesi GA, Hejjas M, Kiyokawa H, Fukada K, Cuypers T, Saeed AA, Al-Rasheed AM, Lin M, Simmonds P. 1994. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. J Clin Microbiol 32:884-892.
26. Mellor J, Holmes EC, Jarvis LM, Yap PL, Simmonds P. 1995. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: Implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 76:2493-2507.
27. Nguyen MH, Keeffe EB. 2005a. Chronic hepatitis C: Genotypes 4 to 9. Clin Liver Dis 9:411-426.
28. Nguyen MH, Keeffe EB. 2005b. Prevalence and treatment of hepatitis C virus genotypes 4, 5 and 6. Clin Gastroenterol Hepatol 3:S97-S101.
29. Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, Henquell C, Abergel A, Pawlotsky JM, Hezode C, Coude M, Blanchi A, Alain S, Loustaud-Ratti V, Chevallier P, Trepo C, Gerolami V, Portal I, Halfon P, Bourliere M, Bogard M, Plouvier E, Laffont C, Agius G, Silvain C, Brodard V, Thiefin G, Buffet-Janvresse C, Riachi G, Grattard F, Bourlet T, Stoll-Keller F, Doffoel M, Izopet J, Barange K, Martinot-Peignoux M, Branger M, Rosenberg A, Sogni P, Chaix ML, Pol S, Thibault V, Opolon P, Charrois A, Serfaty L, Fouqueray B, Grange JD, Lefrere JJ, Lunel-Fabiani F. 2005. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat 12:405-413.
30. Popovski ZT, Dimovski AJ, Simjanovska LJ, Chalovska V, Trajanovski D, Grunevska V, Stefanovska V, Chicole A, Polenakovic M, Zisovski N, Efremov GD. 1996. Molecular detection and characterization of hepatitis C virus in the Republic of Macedonia. Makedon Med Pregl 50:85-90.
31. Roffi L, Redaelli A, Colloredo G, Minola E, Donada C, Picciotto A, Riboli P, Del Poggio P, Rinaldi G, Paris B, Fornaciari G, Giusti M, Marin R, Morales R, Sangiovanni A, Belloni G, Pozzi M, Poli G, Mascoli N, Corradi C, Pioltelli P, Scalori A, Mancia G. 2001. Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: Influence of HCV genotype. Eur J Gastroenterol Hepatol 13:501-506.
32. Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M. 2000. Changes in the epidemiology of hepatitis C infection in Germany: Shift in the predominance of hepatitis C subtypes. J Med Virol 60:122-125.
33. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board A, Belgium. 1999. Global surveillance and control of hepatitis C. J Viral Hepat 6:35-47.
34. Savvas SP, Koskinas J, Sinani C, Hadziyannis A, Spanou F, Hadziyannis SJ. 2005. Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat 12:551-557.
35. Seme K, Vrhovac M, Mocilnik T, Maticic M, Lesnicar G, Baklan Z, Volkar JM, Rajter M, Stepec S, Lunar M, Poljak M. 2009. Hepatitis C virus genotypes in 1, 504 patients in Slovenia, 1993-2007. J Med Virol 81:634-639.
36. Simjanovska LJ, Porcu K, Amitov V, Efremov GD, Polenakovic M. 2004. Reverse transcriptase/polymerase chain reaction analyses of hemodialysis ultrafiltrates and sera of hepatitis C virus positive patients. Int J Artif Organs 27:35-39.
37. Simmonds P. 1999. Viral heterogeneity of the hepatitis C virus. J Hepatol 31:54-60.
38. Simmonds P. 2004. Genetic diversity and evolution of hepatitis C virus-15 Years on. J Gen Virol 85:3173-3188.
39. Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Urdea MS, Holmes EC. 1994. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 75:1053-1061.
40. Soriano V, Bravo R, Garcia-Samaniego J, Castro A, Carballo E, Gonzalez-Anglada I, Martinez-Odriozola P, Colmenero M, Pedreira J. 1996. Circulating hepatitis C virus genotypes in Spain. The Hepatitis/HIV Spanish Study Group. Vox Sang 70:180-181.
41. Stamenkovic G, Zerjav S, Velickovic ZM, Krtolica K, Samardzija VL, Jemuovic L, Nozic D, Dimitrijevic B. 2000. Distribution of HCV genotypes among risk groups in Serbia. Eur J Epidemiol 16:949-954.
42. Sultana C, Oprisan G, Szmal C, Vagu C, Temereanca A, Dinu S, Teleman MD, Ruta S. 2011. Molecular epidemiology of hepatitis C virus strains from Romania. J Gastrointestin Liver Dis 20:261-266.
43. Svirtlih N, Delic D, Simonovic J, Jevtovic D, Dokic L, Gvozdenovic E, Boricic I, Terzic D, Pavic S, Neskovic G, Zerjav S, Urban V. 2007. Hepatitis C virus genotypes in Serbia and Montenegro: The prevalence and clinical significance. World J Gastroenterol 13:355-360.
44. Takada N, Takase S, Takada A, Date T. 1992. HCV genotypes in different countries. Lancet 339:808.
45. Thompson ND, Novak RT, Datta D, Cotter S, Arduino MJ, Patel PR, Williams IT, Bialek SR. 2009. Hepatitis C virus transmission in hemodialysis units: Importance of infection control practices and aseptic technique. Infect Control Hosp Epidemiol 30:900-903.
46. Vince A, Iscic-Bes J, Zidovec Lepej S, Baca-Vrakela I, Bradaric N, Kurelac I, Vince DB. 2006. Distribution of hepatitis C virus genotypes in Croatia-A 10 year retrospective study of four geographic regions. Coll Antropol 30:139-143.
47. Zein NN. 2000. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13:223-235.